Literature DB >> 8512489

Pharmacologic induction of posterior vitreous detachment in the rabbit.

T C Verstraeten1, C Chapman, M Hartzer, B S Winkler, M T Trese, G A Williams.   

Abstract

OBJECTIVE: To assay the proteolytic activity of plasmin on the vitreoretinal junction and to assess a potential facilitating effect on posterior vitreous detachment.
METHODS: We injected 1 U of plasmin into the vitreous of rabbits. Some eyes underwent vitrectomy after plasmin injection. Electroretinography and electron microscopy were performed.
RESULTS: In plasmin-treated eyes, electroretinography displayed a transient (3 days) decreased b-wave amplitude. Histologic examination demonstrated posterior vitreous detachment in eyes that received intravitreal plasmin followed by vitrectomy.
CONCLUSION: Plasmin may prove to be a useful biochemical adjunct to mechanical vitrectomy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512489     DOI: 10.1001/archopht.1993.01090060139038

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy.

Authors:  A Gandorfer; E Putz; U Welge-Lüssen; M Grüterich; M Ulbig; A Kampik
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients.

Authors:  J Sebag; Rafat R Ansari; Kwang I Suh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

3.  Molecular biology of pharmacologic vitreolysis.

Authors:  J Sebag
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  [Pharmacological vitreolysis].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

5.  Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.

Authors:  M Hermel; M Mahgoub; T Youssef; M I Azrak; H Raza; C Alldredge; M Trese; G A Williams; M Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-20       Impact factor: 3.117

6.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

7.  A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.

Authors:  Martin Hermel; Wendelin Dailey; Michael Trese; Michael K Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-03       Impact factor: 3.117

8.  Vitreomacular traction syndrome: a comparison of treatment with intravitreal plasmin enzyme vs spontaneous vitreous separation without treatment.

Authors:  M Codenotti; G Maestranzi; U De Benedetto; G Querques; P Della Valle; L Iuliano; G Fogliato; A D'Angelo; F Bandello
Journal:  Eye (Lond)       Date:  2012-12-14       Impact factor: 3.775

9.  Ocriplasmin for treatment of stage 2 macular holes: early clinical results.

Authors:  John B Miller; Leo A Kim; David M Wu; Demetrios G Vavvas; Dean Eliott; Deeba Husain
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Jul-Aug       Impact factor: 1.300

10.  Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Authors:  Martin Hermel; Jonathan Prenner; Motaz Alabdulrazzak; Wendy Dailey; Michael Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.